{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:00:02Z","timestamp":1793350802881,"version":"4.5.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.addr.2021.113956","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:17:40Z","timestamp":1630495060000},"page":"113956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Vaginal delivery of vaccines"],"prefix":"10.1016","volume":"178","author":[{"given":"Hannah M.","family":"VanBenschoten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Woodrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S4","key":"10.1016\/j.addr.2021.113956_b0005","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/iai.65.4.1387-1394.1997","article-title":"Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women","volume":"65","author":"Kozlowski","year":"1997","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.addr.2021.113956_b0015","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/aji.12230","article-title":"The structure of the human vaginal stratum corneum and its role in immune defense","volume":"71","author":"Anderson","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1095\/biolreprod.110.090423","article-title":"Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia","volume":"85","author":"Blaskewicz","year":"2011","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.immunol.25.022106.141634","article-title":"Mucosal dendritic cells","volume":"25","author":"Iwasaki","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.addr.2021.113956_b0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cyto.2009.09.005","article-title":"Modulation of human \u03b2-defensin-2 expression by 17\u03b2-estradiol and progesterone in vaginal epithelial cells","volume":"49","author":"Han","year":"2010","journal-title":"Cytokine."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0035","doi-asserted-by":"crossref","first-page":"e19560","DOI":"10.1371\/journal.pone.0019560","article-title":"Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1\u00df and lactoferrin","volume":"6","author":"Spear","year":"2011","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.0105-2896.2005.00287.x","article-title":"Innate and adaptive immunity in female genital tract: cellular responses and interactions","volume":"206","author":"Wira","year":"2005","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2249.2005.02660.x","article-title":"Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina","volume":"139","author":"Pellis","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0050","first-page":"1","article-title":"Vaginal mucosal immunity","volume":"4","author":"Hilbert","year":"2011","journal-title":"Lab."},{"key":"10.1016\/j.addr.2021.113956_b0055","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1189\/jlb.69.6.899","article-title":"Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection","volume":"69","author":"Godaly","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2021.113956_b0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1095\/biolreprod60.2.508","article-title":"Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells","volume":"60","author":"Fichorova","year":"1999","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.addr.2021.113956_b0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-065X.2006.00437.x","article-title":"TGF-\u03b2: A mobile purveyor of immune privilege","volume":"213","author":"Wahl","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.113956_b0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0897.2007.00566.x","article-title":"Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia","volume":"59","author":"Herbst-Kralovetz","year":"2008","journal-title":"Am. J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.addr.2021.113956_b0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/mi.2008.57","article-title":"Dendritic cells and macrophages in the genitourinary tract","volume":"1","author":"Iijima","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0080","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI98943","article-title":"HIV-1 replicates and persists in vaginal epithelial dendritic cells","volume":"128","author":"Pena-Cruz","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm1541","article-title":"Langerin is a natural barrier to HIV-1 transmission by Langerhans cells","volume":"13","author":"de Witte","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0090","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/mi.2012.104","article-title":"Functional diversity of human vaginal APC subsets in directing T-cell responses","volume":"6","author":"Duluc","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"14","key":"10.1016\/j.addr.2021.113956_b0095","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.vaccine.2013.10.010","article-title":"Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections","volume":"32","author":"Brotman","year":"2014","journal-title":"Vaccine."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.it.2018.01.007","article-title":"Immunology of the uterine and vaginal mucosae","volume":"39","author":"Zhou","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2012.05.006","article-title":"Unique features of antiviral immune system of the vaginal mucosa","volume":"24","author":"Kumamoto","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0110","doi-asserted-by":"crossref","unstructured":"S.K. Lee, C.J. Kim, D. Kim, J. Kang, Immune cells in the female reproductive tract, 15 (2015) 16\u201326.","DOI":"10.4110\/in.2015.15.1.16"},{"issue":"12","key":"10.1016\/j.addr.2021.113956_b0115","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1128\/iai.65.12.5198-5208.1997","article-title":"Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis","volume":"65","author":"Kelly","year":"1997","journal-title":"Infect. Immun."},{"issue":"14","key":"10.1016\/j.addr.2021.113956_b0120","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1128\/JVI.79.14.9228-9235.2005","article-title":"CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little","volume":"79","author":"Reynolds","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2021.113956_b0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1254536","article-title":"Resident memory CD8 T cells trigger protective innate and adaptive immune responses","volume":"346","author":"Schenkel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.addr.2021.113956_b0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2568","article-title":"Sensing and alarm function of resident memory CD8+ T cells","volume":"14","author":"Schenkel","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0135","article-title":"Vaginal type-II mucosa is an inductive site for primary CD8+ T-cell mucosal immunity","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/mi.2012.48","article-title":"Delayed but effective induction of mucosal memory immune responses against genital HSV-2 in the absence of secondary lymphoid organs","volume":"6","author":"Roth","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0145","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/mi.2017.89","article-title":"Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization","volume":"11","author":"Tan","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.addr.2021.113956_b0150","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1073\/pnas.1012861108","article-title":"Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection","volume":"108","author":"Li","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2021.113956_b0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0897.1998.tb00355.x","article-title":"Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract","volume":"39","author":"Kaushic","year":"1998","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0160","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1210\/endo.141.8.7594","article-title":"Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells","volume":"141","author":"Wira","year":"2000","journal-title":"Endocrinology."},{"key":"10.1016\/j.addr.2021.113956_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0897.2011.00970.x","article-title":"Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections","volume":"65","author":"Wira","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0170","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.138.12.4159","article-title":"Specific IgA and IgG antibodies in the secretions of the female reproductive tract: effects of immunization and estradiol on expression of this response in vivo","volume":"138","author":"Wira","year":"1987","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/imr.12072","article-title":"Mucosal immunology of HIV infection","volume":"254","author":"Xu","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2021.113956_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":"Hormonal contraceptive use and risk of HIV-1 transmission: a prospective cohort analysis","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.addr.2021.113956_b0185","first-page":"1","article-title":"Estrogen action in the epithelial cells of the mouse vagina regulates neutrophil infiltration and vaginal tissue integrity","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0190","doi-asserted-by":"crossref","first-page":"e1005589","DOI":"10.1371\/journal.ppat.1005589","article-title":"Estradiol enhances CD4+ T-cell anti-viral immunity by priming vaginal DCs to induce Th17 responses via an IL-1-dependent pathway","volume":"12","author":"Anipindi","year":"2016","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0195","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/JVI.79.5.3117-3126.2005","article-title":"Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue","volume":"79","author":"Gillgrass","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2021.113956_b0200","unstructured":"UNAIDS, Global HIV Statistics, End. AIDS Epidemic. (2020) 1\u20133."},{"key":"10.1016\/j.addr.2021.113956_b0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0210","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.addr.2021.113956_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8030391","article-title":"Human papillomavirus vaccines: An updated review","volume":"8","author":"Cheng","year":"2020","journal-title":"Vaccines."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0220","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","article-title":"Current understanding of the mechanism of HPV infection","volume":"118","author":"Schiller","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.addr.2021.113956_b0225","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/intimm\/13.5.633","article-title":"Physical interaction of human papillomavirus virus-like particles with immune cells","volume":"13","author":"Da Silva","year":"2001","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.virol.2003.11.004","article-title":"Kinetics of in vitro adsorption and entry of papillomavirus virions","volume":"319","author":"Culp","year":"2004","journal-title":"Virology."},{"key":"10.1016\/j.addr.2021.113956_b0235","first-page":"80","article-title":"Review of HPV-related diseases and cancers","volume":"40","author":"Brianti","year":"2017","journal-title":"New Microbiol."},{"issue":"2","key":"10.1016\/j.addr.2021.113956_b0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CDLI.8.2.209-220.2001","article-title":"Cell-mediated immune response to human papillomavirus infection","volume":"8","author":"Scott","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-5-19","article-title":"HPV - Immune response to infection and vaccination","volume":"5","author":"Stanley","year":"2010","journal-title":"Infect. Agent. Cancer."},{"key":"10.1016\/j.addr.2021.113956_b0250","first-page":"3967","article-title":"Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology","volume":"56","author":"Tsukui","year":"1996","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.addr.2021.113956_b0255","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/21645515.2015.1103936","article-title":"HPV vaccines: translating immunogenicity into efficacy","volume":"12","author":"Turner","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"issue":"2-3","key":"10.1016\/j.addr.2021.113956_b0260","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0264-410X(00)00173-0","article-title":"Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization","volume":"19","author":"Schreckenberger","year":"2000","journal-title":"Vaccine."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0265","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jmv.10442","article-title":"Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems","volume":"70","author":"Park","year":"2003","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0270","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/jir747","article-title":"Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples","volume":"205","author":"Hughes","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0010-7824(99)00058-X","article-title":"The effect of one injection of Depo-Provera\u00ae on the human vaginal epithelium and cervical ectopy","volume":"60","author":"Mauck","year":"1999","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2021.113956_b0280","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1677\/joe.1.06873","article-title":"Cyclic changes in the vaginal epithelium of normal rhesus macaques","volume":"190","author":"Poonia","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.addr.2021.113956_b0285","doi-asserted-by":"crossref","unstructured":"M.R. Anderson, S.M. Baig, C.J. Gioia, E.J. Spongberg, M. Sarah, Human cervicovaginal mucus contains an activity that hinders HIV-1 movement, 6 (2013) 427\u2013434. https:\/\/doi.org\/10.1038\/mi.2012.87.Human.","DOI":"10.1038\/mi.2012.87"},{"key":"10.1016\/j.addr.2021.113956_b0290","first-page":"435","article-title":"Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys","volume":"78","author":"Hu","year":"1998","journal-title":"Lab. Investig."},{"key":"10.1016\/j.addr.2021.113956_b0295","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2003-09-3129","article-title":"Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells","volume":"103","author":"Turville","year":"2004","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.addr.2021.113956_b0300","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00002030-200305230-00004","article-title":"Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women","volume":"17","author":"Kaul","year":"2003","journal-title":"Aids."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0305","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity."},{"key":"10.1016\/j.addr.2021.113956_b0310","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri2836","article-title":"Antiviral immune responses in the genital tract: clues for vaccines","volume":"10","author":"Iwasaki","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.addr.2021.113956_b0315","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1172\/JCI63287","article-title":"Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses","volume":"122","author":"\u00c7uburu","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"7272","key":"10.1016\/j.addr.2021.113956_b0320","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature08511","article-title":"CD8 + T lymphocyte mobilization to virus-infected tissue requires CD4 + T-cell help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0325","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI45157","article-title":"Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections","volume":"121","author":"Zeng","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2021.113956_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3003165","article-title":"HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome","volume":"4","author":"Soghoian","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.addr.2021.113956_b0335","doi-asserted-by":"crossref","first-page":"e1002890","DOI":"10.1371\/journal.ppat.1002890","article-title":"ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIVmac251 challenge","volume":"8","author":"Alpert","year":"2012","journal-title":"PLoS Pathog."},{"issue":"16","key":"10.1016\/j.addr.2021.113956_b0340","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1089\/08892220260387940","article-title":"Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS","volume":"18","author":"Banks","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0345","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.4049\/jimmunol.174.4.2185","article-title":"Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIV mac251","volume":"174","author":"G\u00f3mez-Rom\u00e1n","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.addr.2021.113956_b0350","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.4049\/jimmunol.0803115","article-title":"Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with tat\/env compared with multigenic vaccines","volume":"182","author":"Florese","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0355","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1517\/14712598.2010.496776","article-title":"Mucosal HIV transmission and vaccination strategies through oral compared to vaginal and rectal routes","volume":"10","author":"Yu","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0360","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/mi.2009.110","article-title":"Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses","volume":"3","author":"Cranage","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2017.01.018","article-title":"Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses","volume":"249","author":"McKay","year":"2017","journal-title":"J. Control. Release."},{"issue":"21","key":"10.1016\/j.addr.2021.113956_b0370","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.vaccine.2007.11.002","article-title":"Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN\/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 study","volume":"26","author":"Pialoux","year":"2008","journal-title":"Vaccine."},{"issue":"9","key":"10.1016\/j.addr.2021.113956_b0375","doi-asserted-by":"crossref","first-page":"e25165","DOI":"10.1371\/journal.pone.0025165","article-title":"Phase I randomised clinical trial of an HIV-1 CN54, clade C, trimeric envelope vaccine candidate delivered vaginally","volume":"6","author":"Lewis","year":"2011","journal-title":"PLoS One."},{"issue":"20","key":"10.1016\/j.addr.2021.113956_b0380","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1128\/JVI.01621-14","article-title":"Effect of vaginal immunization with HIVgp140 and HSP70 on HIV-1 replication and innate and T cell adaptive immunity in women","volume":"88","author":"Lewis","year":"2014","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0385","doi-asserted-by":"crossref","first-page":"e0152038","DOI":"10.1371\/journal.pone.0152038","article-title":"Comparative immunogenicity of HIV-1 gp140 vaccine delivered by parenteral, and mucosal routes in female volunteers; MUCOVAC2, a randomized two centre study","volume":"11","author":"Cosgrove","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.addr.2021.113956_b0390","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-3659(97)00114-4","article-title":"Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina","volume":"50","author":"Wyatt","year":"1998","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.113956_b0395","doi-asserted-by":"crossref","unstructured":"R.J. Morrow, A.D. Woolfson, L. Donnelly, R. Curran, Sustained release of proteins from a modified vaginal ring device, 77 (2013) 3\u201310. https:\/\/doi.org\/10.1016\/j.ejpb.2010.10.010.Sustained.","DOI":"10.1016\/j.ejpb.2010.10.010"},{"issue":"2-3","key":"10.1016\/j.addr.2021.113956_b0400","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0168-3659(02)00354-1","article-title":"Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix","volume":"86","author":"Shen","year":"2003","journal-title":"J. Control. Release."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0405","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1021\/mp100009e","article-title":"Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity","volume":"7","author":"Kuo-Haller","year":"2010","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0410","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jmv.2144","article-title":"Induction of mucosal IgA following intravaginal administration of inactivated HIV-1-capturing nanospheres in mice","volume":"66","author":"Kawamura","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.addr.2021.113956_b0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biomaterials.2017.03.007","article-title":"Engineering intravaginal vaccines to overcome mucosal and epithelial barriers","volume":"128","author":"Ji","year":"2017","journal-title":"Biomaterials."},{"issue":"7","key":"10.1016\/j.addr.2021.113956_b0420","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.vaccine.2010.12.034","article-title":"Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation","volume":"29","author":"Cranage","year":"2011","journal-title":"Vaccine."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0425","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejps.2012.02.003","article-title":"Development of liposome gel based formulations for intravaginal delivery of the recombinant HIV-1 envelope protein CN54gp140","volume":"46","author":"Gupta","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"48","key":"10.1016\/j.addr.2021.113956_b0430","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1016\/j.vaccine.2009.08.088","article-title":"Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses","volume":"27","author":"Curran","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.addr.2021.113956_b0435","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0264-410X(02)00779-X","article-title":"Enhanced mucosal and systemic immune responses to a vaginal vaccine coadministered with RANTES-expressing plasmid DNA using in situ-gelling mucoadhesive delivery system","volume":"21","author":"Oh","year":"2003","journal-title":"Vaccine."},{"issue":"1-2","key":"10.1016\/j.addr.2021.113956_b0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2010.05.040","article-title":"Local gene expression and immune responses of vaginal DNA vaccination using a needle-free injector","volume":"396","author":"Kanazawa","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.addr.2021.113956_b0445","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2013.02.018","article-title":"Needle-free intravaginal DNA vaccination using a stearoyl oligopeptide carrier promotes local gene expression and immune responses","volume":"447","author":"Kanazawa","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0450","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08830180305228","article-title":"Vaginal immunity in the HSV-2 mouse model","volume":"22","author":"Parr","year":"2003","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002030-198802000-00008","article-title":"Genital ulceration as a risk factor for human immunodeficiency virus infection","volume":"2","author":"Greenblatt","year":"1988","journal-title":"AIDS."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrmicro794","article-title":"The role of sexually transmitted diseases in HIV transmission","volume":"2","author":"Galvin","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.addr.2021.113956_b0465","doi-asserted-by":"crossref","first-page":"438","DOI":"10.15698\/mic2016.09.528","article-title":"Genital herpes: insights into sexually transmitted infectious disease","volume":"3","author":"Jaishankar","year":"2016","journal-title":"Microb. Cell."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2000.0529","article-title":"Three classes of cell surface receptors for alphaherpesvirus entry","volume":"275","author":"Spear","year":"2000","journal-title":"Virology."},{"issue":"s1","key":"10.1016\/j.addr.2021.113956_b0475","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/505359","article-title":"The cycle of human herpes simplex virus infection: virus transport and immune control","volume":"194","author":"Cunningham","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2021.113956_b0480","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/515236","article-title":"In vivo production of cytokines and \u03b2 (C-C) chemokines in human recurrent herpes simplex lesions - Do herpes simplex virus - Infected keratinocytes contribute to their production?","volume":"177","author":"Mikloska","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2021.113956_b0485","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1084\/jem.20021109","article-title":"Vaginal submucosal dendritic cells, but not langerhans cells, induce protective Th1 responses to herpes simplex virus-2","volume":"197","author":"Zhao","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2021.113956_b0490","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1099\/0022-1317-82-4-845","article-title":"Differential roles of B cells and IFN-\u03b3-secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice","volume":"82","author":"Harandi","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.addr.2021.113956_b0495","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/173.1.7","article-title":"Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-\u03b3","volume":"173","author":"Mikloska","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"18","key":"10.1016\/j.addr.2021.113956_b0500","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1073\/pnas.1202288109","article-title":"Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation","volume":"109","author":"Mackay","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7424","key":"10.1016\/j.addr.2021.113956_b0505","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.addr.2021.113956_b0510","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/jit651","article-title":"Correlate of immune protection against HSV-1 genital disease in vaccinated women","volume":"209","author":"Belshe","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.addr.2021.113956_b0515","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1128\/JVI.72.6.5137-5145.1998","article-title":"Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2","volume":"72","author":"Parr","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2021.113956_b0520","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2567.1999.00909.x","article-title":"Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2","volume":"98","author":"Parr","year":"1999","journal-title":"Immunology."},{"issue":"12","key":"10.1016\/j.addr.2021.113956_b0525","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1073\/pnas.86.12.4736","article-title":"Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate","volume":"86","author":"Coen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2021.113956_b0530","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/mi.2008.81","article-title":"A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge","volume":"2","author":"Zhang","year":"2009","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/JVI.02380-14","article-title":"Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB\/gD ectodomains induces genital-tissue-resident memory CD8 + T cells and reduces genital disease and viral shedding after HSV-2 challenge","volume":"89","author":"\u00c7uburu","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0540","first-page":"1021","article-title":"Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2","volume":"9","author":"He","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.addr.2021.113956_b0545","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2016.12.009","article-title":"Combining different types of multifunctional liposomes loaded with ammonium bicarbonate to fabricate microneedle arrays as a vaginal mucosal vaccine adjuvant-dual delivery system (VADDS)","volume":"246","author":"Wang","year":"2017","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.113956_b0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00500","article-title":"An intra-vaginal zinc oxide tetrapod nanoparticles (zoten) and genital herpesvirus cocktail can provide a novel platform for live virus vaccine","volume":"10","author":"Agelidis","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.addr.2021.113956_b0555","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.4049\/jimmunol.1502373","article-title":"Intravaginal zinc oxide tetrapod nanoparticles as novel immunoprotective agents against genital herpes","volume":"196","author":"Antoine","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0560","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1172\/JCI119136","article-title":"Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis","volume":"99","author":"Rasmussen","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"S2","key":"10.1016\/j.addr.2021.113956_b0565","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/652397","article-title":"Pathogenesis of genital tract disease due to chlamydia trachomatis","volume":"201","author":"Darville","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.addr.2021.113956_b0570","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2015.02.004","article-title":"A re-evaluation of the role of B cells in protective immunity to Chlamydia infection","volume":"164","author":"Li","year":"2015","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.addr.2021.113956_b0575","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1128\/IAI.68.9.5293-5298.2000","article-title":"Characterization of lymphocyte response in the female genital tract during ascending chlamydial genital infection in the guinea pig model","volume":"68","author":"Moore","year":"2000","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.addr.2021.113956_b0580","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/iai.56.9.2243-2249.1988","article-title":"Susceptibility to reinfection after a primary chlamydial genital infection","volume":"56","author":"Rank","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2021.113956_b0585","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/652400","article-title":"Protective immunity to chlamydia trachomatis genital infection: evidence from human studies","volume":"201","author":"Batteiger","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.addr.2021.113956_b0590","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.vaccine.2005.08.097","article-title":"Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine."},{"issue":"32","key":"10.1016\/j.addr.2021.113956_b0595","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1016\/j.vaccine.2011.05.013","article-title":"Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine","volume":"29","author":"Carmichael","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.addr.2021.113956_b0600","unstructured":"E.E. Ekong, D.N. Okenu, J. Mania-pramanik, Q. He, U. Joseph, G.A. Ananaba, D. Lyn, C. Black, F.O. Eko, A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin, (2011) 1\u201319. https:\/\/doi.org\/10.1111\/j.1574-695X.2008.00493.x.A."},{"issue":"7","key":"10.1016\/j.addr.2021.113956_b0605","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.vaccine.2010.12.042","article-title":"Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa","volume":"29","author":"Schautteet","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.addr.2021.113956_b0610","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MOH.0000000000000394","article-title":"Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae","volume":"25","author":"Stevens","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.addr.2021.113956_b0615","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/cmi.12411","article-title":"The lipooligosaccharide modifying enzyme LptA enhances gonococcal defense against human neutrophils","volume":"17","author":"Handling","year":"2015","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.addr.2021.113956_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.02417","article-title":"Progress toward a gonococcal vaccine: the way forward","volume":"10","author":"Russell","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.addr.2021.113956_b0625","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/infdis\/jit354","article-title":"Enhancement of adaptive immunity to neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12","volume":"208","author":"Liu","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0630","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/01.ju.0000075094.54767.6e","article-title":"Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections","volume":"170","author":"Uehling","year":"2003","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0635","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.juro.2006.11.093","article-title":"Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial","volume":"177","author":"Hopkins","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.addr.2021.113956_b0640","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1573395514666180605092054","article-title":"Mucosal vaccine approaches for prevention fo HIV and SIV transmission","volume":"15","author":"Kozlowski","year":"2019","journal-title":"Curr. Immunol. Rev."},{"issue":"13","key":"10.1016\/j.addr.2021.113956_b0645","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0264-410X(99)00385-0","article-title":"Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses","volume":"18","author":"Kato","year":"2000","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.addr.2021.113956_b0650","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/clim.2001.5141","article-title":"Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine","volume":"102","author":"Hamajima","year":"2002","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.addr.2021.113956_b0655","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.176.5.2749","article-title":"Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin","volume":"176","author":"Luci","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.addr.2021.113956_b0660","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/JVI.77.2.953-962.2003","article-title":"A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection","volume":"77","author":"Harandi","year":"2003","journal-title":"J. Virol."},{"issue":"23-24","key":"10.1016\/j.addr.2021.113956_b0665","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2004.01.059","article-title":"Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2","volume":"22","author":"Kwant","year":"2004","journal-title":"Vaccine."},{"issue":"11","key":"10.1016\/j.addr.2021.113956_b0670","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1128\/JVI.02013-05","article-title":"Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes","volume":"80","author":"Tengvall","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2021.113956_b0675","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2014.03.018","article-title":"Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines","volume":"183","author":"Klein","year":"2014","journal-title":"J. Control. Release."},{"issue":"16","key":"10.1016\/j.addr.2021.113956_b0680","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1128\/JVI.00781-11","article-title":"Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge","volume":"85","author":"Tan","year":"2011","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.addr.2021.113956_b0685","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.4049\/jimmunol.165.9.5077","article-title":"Vaginal mucosa serves as an inductive site for tolerance","volume":"165","author":"Black","year":"2000","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.addr.2021.113956_b0690","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1128\/JVI.77.18.9845-9851.2003","article-title":"Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2","volume":"77","author":"Gillgrass","year":"2003","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.addr.2021.113956_b0695","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/iai.64.3.974-979.1996","article-title":"Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant","volume":"64","author":"Di Tommaso","year":"1996","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.addr.2021.113956_b0700","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/iai.65.7.2676-2684.1997","article-title":"Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina","volume":"65","author":"Bergquist","year":"1997","journal-title":"Infect. Immun."},{"issue":"16","key":"10.1016\/j.addr.2021.113956_b0705","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/0264-410X(95)00100-F","article-title":"Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus","volume":"13","author":"Scott Gallichan","year":"1995","journal-title":"Vaccine."},{"issue":"2","key":"10.1016\/j.addr.2021.113956_b0710","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/mi.2013.45","article-title":"Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells","volume":"7","author":"Hervouet","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.addr.2021.113956_b0715","doi-asserted-by":"crossref","first-page":"e9281","DOI":"10.1371\/journal.pone.0009281","article-title":"CD8+ DC, but not CD8-DC, isolated from BCG-infected mice reduces pathological reactions induced by mycobacterial challenge infection","volume":"5","author":"Gao","year":"2010","journal-title":"PLoS One."},{"key":"10.1016\/j.addr.2021.113956_b0720","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2020.10.012","article-title":"Flt3-L enhances trans-epithelial migration and antigen presentation of dendritic cells adoptively transferred to genital mucosa","volume":"329","author":"Park","year":"2021","journal-title":"J. Control. Release."},{"issue":"12","key":"10.1016\/j.addr.2021.113956_b0725","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/324581","article-title":"Human immunodeficiency virus type 1 gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles","volume":"184","author":"Vajdy","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.addr.2021.113956_b0730","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1128\/JVI.79.11.7135-7145.2005","article-title":"Characterization of human immunodeficiency virus gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles","volume":"79","author":"Gupta","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.addr.2021.113956_b0735","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4049\/jimmunol.180.4.2504","article-title":"Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge","volume":"180","author":"Li","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.addr.2021.113956_b0740","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4049\/jimmunol.1101404","article-title":"Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA","volume":"188","author":"Gordon","year":"2012","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.addr.2021.113956_b0745","doi-asserted-by":"crossref","first-page":"e67574","DOI":"10.1371\/journal.pone.0067574","article-title":"Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV","volume":"8","author":"Weaver","year":"2013","journal-title":"PLoS One."},{"issue":"21","key":"10.1016\/j.addr.2021.113956_b0750","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.vaccine.2014.02.077","article-title":"Exploring mucosal immunization with a recombinant influenza virus carrying an HIV-polyepitope in mice with pre-existing immunity to influenza","volume":"32","author":"Garulli","year":"2014","journal-title":"Vaccine."},{"issue":"9","key":"10.1016\/j.addr.2021.113956_b0755","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.4049\/jimmunol.1201121","article-title":"Targeting the genital tract mucosa with a lipopeptide\/recombinant adenovirus prime\/boost vaccine induces potent and long-lasting CD8 + T cell immunity against herpes: importance of MyD88","volume":"189","author":"Zhang","year":"2012","journal-title":"J. Immunol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21003495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21003495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:06:05Z","timestamp":1759208765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":151,"alternative-id":["S0169409X21003495"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.113956","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal delivery of vaccines","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.113956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113956"}}